Cardiac Myosin Inhibitor Sustainably Reduces LVOT Gradient in HCM

Media Formats

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Comments

Overview
Dr. Maya Guglin explains the pathophysiology of hypertrophic cardiomyopathy (HCM) and discusses what the results of the long-term extension study of EXPLORER-HCM could mean for patients with symptomatic obstructive HCM.

Recommended

Details

Comments

Overview
Dr. Maya Guglin explains the pathophysiology of hypertrophic cardiomyopathy (HCM) and discusses what the results of the long-term extension study of EXPLORER-HCM could mean for patients with symptomatic obstructive HCM.